Core programs
From the annual summit to the registry initiative, every program is designed to remove friction between great congenital cardiovascular ideas and the patients they could reach.
The flagship convening: cardiologists, ACHD specialists, surgeons, medtech founders, AI companies, regulators, investors and hospital procurement leaders — together for the first time at the scale the field deserves.
Startup, corporate, clinical, academic, strategic partner and investor tiers — with networking, speaking opportunities, regulatory briefings, collaboration access and investor introductions.
A working group across FDA, Health Canada and EMA pathways, pediatric approvals, HDE strategy, reimbursement frameworks and HTA support.
Clinical advisory access, pilot project facilitation, KOL matchmaking, commercialization mentorship, grant collaboration and venture readiness support.
Shared outcomes registries, real-world evidence databases, multi-center frameworks, AI training datasets and longitudinal outcome tracking — a strategic long-term differentiator.
Market reports, regulatory briefings and quarterly insights mapping the global congenital cardiovascular technology landscape.
Phased rollout
Founding advisory board, anchor sponsors, brand identity, stakeholder outreach, founding members.
Inaugural summit, working groups, regulatory roundtables, industry insights, investor engagement.
Registry initiatives, policy influence, global expansion, accreditation, standards and research programs.